美皓集團(01947.HK)盈警:預期年度淨虧損約1100萬元至1400萬元
格隆匯2月27日丨美皓集團(01947.HK)公吿,根據董事會目前可得資料及對集團截至2023年12月31日止年度未經審核綜合管理賬目的初步審閲,集團預期將錄得淨虧損約人民幣1100萬元至約人民幣1400萬元(截至2022年12月31日止年度:淨利潤人民幣2860萬元)。
預計虧損主要由於以下原因所致:(i)2019冠狀病毒疫情防控措施解除,感染數字上升,致使求診人數減少,加上消費市場整體衰退;(ii)自2023年4月1日起,受温州市種植牙集採政策執行影響,導致種植牙科服務收入以及毛利潤大幅下降;(iii)2023年度公司自上市後引進各部門高層管理人才,作為集團戰略性發展人才儲備,另上市後相關合規費用有所提升,導致行政及管理費用顯著的增加。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.